A Study to Evaluate the Effect of Jaktinib on QT/QTc Interval in Healthy Participants
Clinical trial NCT06193148 · COMPLETED
Trial details
- NCT number
- NCT06193148
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-19
- Primary completion
- 2024-06-18
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.